Archive · 4 Sep 2025
AI Biotech Startup Uses Nature to Discover New Medicines
Imagine nature has a big medicine cabinet, and Enveda is using a super smart computer (AI) to find new medicines inside plants.
They're looking at thousands of plants used throughout history.
They break these plants down into tiny pieces, analyze them with AI, and see which ones might help with diseases.
The most promising ones are tested further to create new drugs.
Enveda just got a lot of money, showing people believe in this approach.
Their first medicine is going into human trials, and they have more drugs coming.
They hope to make it easier and faster to discover new medicines than ever before.
Enveda is a biotech company using AI to discover drugs from natural plant compounds.
The company recently closed a $150 million funding round, valuing it at over $1 billion.
Enveda has already begun its first clinical trial.
The company uses AI to analyze 12,000 plant samples for potential medicinal properties.
Enveda expects to expand its drug pipeline in the coming months.
- Who
- Enveda, a biotech company, is using AI to discover new medicines from plants.
- What
- Enveda uses AI to analyze plant compounds and identify potential new drugs.
- When
- Founded in 2019, Enveda recently closed a funding round and is starting clinical trials.
- Where
- Boulder, Colorado.
- Why
- To expedite drug discovery by leveraging AI to analyze natural compounds.
- Company Name
- Enveda
- Funding Amount
- $517 million total
- Recent Funding Round
- $150 million Series D
- Valuation
- Over $1 billion
- Founded
- 2019
- Initial Clinical Trial
- First patient enrolled
- Plant Samples
- 12,000